You have 7 free searches left this month | for more free features.

AN05

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Knee Osteoarthritis Trial in United States (CNTX-4975-05, Lidocaine without epinephrine, ElastoGel)

Completed
  • Knee Osteoarthritis
  • Birmingham, Alabama
  • +27 more
Feb 11, 2022

Circulating Prostate Cells Among Adenocarcinoma Patients

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • EPISPOT detection of the number of circulating cells
  • CellSearch detection of the number of circulating, functional, prostate cells
  • Nîmes Cedex 09, Gard, France
  • +4 more
Aug 4, 2021

Osteoarthritis, Knee Trial in United States (CNTX-4975-05, Placebo)

Completed
  • Osteoarthritis, Knee
  • Birmingham, Alabama
  • +32 more
Jul 18, 2022

Allergic Rhinitis Trial in China (Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT, Azelastine Hydrochloride 0.137

Completed
  • Allergic Rhinitis
  • Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT
  • +2 more
  • Beijing, Beijing, China
  • +32 more
Feb 4, 2022

Pancreatic Cancer Trial in Baltimore (drug, biological, radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 3, 2022

Inflammation; Skin Trial in Leiden (Erythromycin 4% topical gel formulation:, Clindamycin 1% lotion formulation:, Prednisolone

Completed
  • Inflammation; Skin
  • Erythromycin 4% topical gel formulation:
  • +4 more
  • Leiden, Zuid-Holland, Netherlands
    Centre for Human Drug Research
Aug 2, 2021

Rheumatoid Arthritis Trial in Poland (CPL409116, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • Bydgoszcz, Poland
  • +6 more
May 10, 2022

Plaque Psoriasis Trial in United States (DFD-01 (betamethasone dipropionate) Spray, 0.05%)

Completed
  • Plaque Psoriasis
  • DFD-01 (betamethasone dipropionate) Spray, 0.05%
  • Arlington Heights, Illinois
  • +3 more
Feb 1, 2021

MDD, Treatment Resistant Depression, Depression Trial in United States (AXS-05)

Completed
  • Major Depressive Disorder
  • +2 more
  • AXS-05 (dextromethorphan and bupropion) oral tablets
  • Phoenix, Arizona
  • +50 more
Sep 16, 2022

HER2-mutant NSCLC Trial in China (Trastuzumab deruxtecan)

Recruiting
  • HER2-mutant Non-Small Cell Lung Cancer
  • Trastuzumab deruxtecan
  • Baoding, China
  • +29 more
Jul 20, 2022

Plaque Psoriasis Trial (Halobetasol Propionate)

Withdrawn
  • Plaque Psoriasis
  • Halobetasol Propionate
  • (no location specified)
Jun 11, 2021

Acute Myocardial Infarction, STEMI, Percutaneous Coronary Revascularization Trial in Worldwide (FDY-5301, Placebo)

Recruiting
  • Acute Myocardial Infarction
  • +2 more
  • Torrance, California
  • +15 more
Aug 8, 2022

Moderate to Severe Plaque Psoriasis Trial in China (KHK4827-Active, KHK4827-Placebo)

Withdrawn
  • Moderate to Severe Plaque Psoriasis
  • Changchun, China
  • +24 more
Sep 24, 2021

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Solid Tumors Trial run by the (EC145)

Completed
  • Solid Tumors
  • Bethesda, Maryland
    Center for Blood and Cancer Disorders
Apr 6, 2021

Tumors, NSCLC Trial in Worldwide (BI 754111, BI 754091)

Active, not recruiting
  • Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • BI 754111
  • BI 754091
  • Miami, Florida
  • +14 more
Jan 9, 2023

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Adhesive Capsulitis Trial in France (equimolar oxygen-nitrous oxide mixture, Placebo)

Completed
  • Adhesive Capsulitis
  • equimolar oxygen-nitrous oxide mixture
  • Placebo
  • Le Grau du Roi, Gard, France
  • +4 more
Feb 5, 2021

Dry Eye Trial in United States (Voclosporin Ophthalmic Solution, Restasis®)

Completed
  • Dry Eye
  • Garden Grove, California
  • +6 more
Jul 5, 2021

Autosomal Dominant Polycystic Kidney Disease Trial in Worldwide (Placebo, GLPG2737)

Active, not recruiting
  • Autosomal Dominant Polycystic Kidney Disease
  • Brussels, Belgium
  • +19 more
Nov 23, 2021

Primary Immune Thrombocytopenia Trial in Worldwide (PF-06835375)

Suspended
  • Primary Immune Thrombocytopenia
  • PF-06835375
  • Jacksonville, Florida
  • +27 more
Jan 25, 2023

Immune Thrombocytopenia, Immune Thrombocytopenic Purpura Trial in Worldwide (PRN1008)

Recruiting
  • Immune Thrombocytopenia
  • Immune Thrombocytopenic Purpura
  • Peoria, Illinois
  • +29 more
May 11, 2022

Atopic Dermatitis Trial in China (CBP-201)

Not yet recruiting
  • Atopic Dermatitis
  • Beijing, Beijing, China
  • +40 more
Jun 14, 2023

Postmenopausal Osteoporosis Trial in Worldwide (Alendronate)

Completed
  • Postmenopausal Osteoporosis
  • Lakewood, Colorado
  • +24 more
Nov 18, 2020

Prostatic Tumors Trial in Worldwide (Prostatectomy/Surgery, Radiotherapy with adjuvant androgen deprivation therapy)

Recruiting
  • Prostatic Neoplasms
  • Prostatectomy/Surgery
  • Radiotherapy with adjuvant androgen deprivation therapy
  • Aalborg, Denmark
  • +29 more
Mar 30, 2022